We Cracked Bakuchiol's Sensitization Challenge | CongenPharma·Got New Patented Technology
Publish Time:
2025-11-26
🔥 We Solved Bakuchiol's Sensitization Problem
Traditional bakuchiol offers excellent efficacy—but comes with phototoxicity and irritation risks. CongenPharma uses innovative molecular modification technology to remove allergenic groups while fully preserving activity: 100% potency, 0 irritation burden.
In cosmetic applications, this patented technology simultaneously enhances bakuchiol's stability and dramatically reduces its cytotoxicity and irritation, enabling higher usage concentrations—and delivering superior efficacy.
💡More crucially: No domestic competitors. Massive potential for overseas import substitution.
The market signal is clear: L'Oréal China's 2023 financial report shows the Active Health Cosmetics division grew 23%.
Old ingredients, or new patents?
This choice determines your market position for the next three years.
✅ Why Choose Us – Key Advantages for R&D and Commercial Partners
1. Joint Support for New Formulation Development We can collaborate with clients on co-development and joint submission of new formulations, providing technical documentation, analytical data, and project support throughout the development cycle.
2. In-house R&D & Analytical Laboratory Our facility includes a fully equipped R&D and analytical testing laboratory & efficacy laboratory with advanced QA/QC capabilities, including
- NMR
- MS
- HPLC This ensures high and consistent quality, reliable analytical validation, and strong technical support for your research projects.
3. Scalable Manufacturing Capacity We offer flexible and scalable production, from R&D quantities to multi-ton commercial batches, ensuring stable supply for both pilot and long-term projects.
4. Fully Integrated Manufacturing – from R&D of new active ingredients to large-scale commercial production, With our own raw-material manufacturing line and integrated production system, we control quality at every step and guarantee supply reliability, traceability, and competitive pricing
📩 For inquiries or bulk orders, contact us at marketing@congenpharm.com
Patent Name: A Non-sensitizing Bakuchiol Derivative, its preparation method and application
Prev:
Relevant Information
undefined
